The spread of antimicrobial resistance is an important emerging health threat in developed countries. Widespread outpatient antimicrobial use leads to the spread of resistance among community-acquired pathogens such as Streptococcus pneumoniae. The Centers for Disease Control and Prevention and partner organizations have initiated a national campaign promoting more judicious antimicrobial use to decrease the spread of resistance. The initial focus is to improve management of respiratory tract infections, which account for most outpatient antimicrobial use. Survey and focus group results indicate that patient pressure and suboptimal diagnosis and treatment contribute to antibiotic overuse. To educate physicians, a series of ''principles of judicious antibiotic use'' have been developed that identify optimal approaches to management of common respiratory infections. Patient education materials and strategies to improve doctor-patient communication also have been developed. Several studies currently under way will evaluate the impact of intervention on antibiotic use practices and resistant carriage or infection.
trol all have a role in confronting this problem. In addition, immunization may diminish the impact of resistance by preThe Emergence of Antimicrobial Resistance venting infection or even decreasing carriage and transmission, as has occurred with Haemophilus influenzae type b The spread of antimicrobial resistance is one of the most important emerging infectious disease threats in the United conjugate vaccine. Although resistant pathogens developed soon after the introStates [1, 2] . This problem, however, is a complex one with multiple causes. Outpatient antimicrobial use has led to the duction of antimicrobial therapy [6] , the spread of resistance among Streptococcus pneumoniae (pneumococci) has made spread of resistance among bacterial respiratory tract pathogens, such as the pneumococcus. For some enteric pathogens, this problem one that virtually no clinician can ignore. Pneumococcal infections, which are the leading cause of communityantimicrobial use in animals is a key contributor to the development and spread of resistant infections [3] . Among nosocomial acquired bacterial meningitis, pneumonia, bacteremia, and otitis media, impact physicians who care for children and adults pathogens, important factors in the spread of resistance include extensive use of broad-spectrum agents in hospitals and personin a range of settings. While all pneumococci remain susceptible to vancomycin and ''untreatable infections'' have not octo-person transmission of resistant strains due to inadequate infection control practices [4] . Finally, other mechanisms, such curred, strains have been identified that are no longer susceptible to any oral antimicrobial agent. This raises the specter that as noncompliance with therapy, may contribute to the spread of resistance among some pathogens such as Mycobacterium some patients with common infections, including otitis media and sinusitis, may need to be treated parenterally at much tuberculosis [5] .
Because multiple factors contribute to the global spread of greater human discomfort and financial cost. resistance, any strategy to address this problem will need to be as varied as its causes. Decreasing unnecessary antibiotic Antimicrobial Use and Resistance use, treating with narrow-spectrum agents whenever possible, improving compliance with therapy, decreasing use of antibi-
The widespread use of antimicrobials has led to the spread of otics in animals and agriculture, and improving infection conresistance among pneumococci and other community-acquired pathogens. The association between antimicrobial use and resistance has been documented in a variety of ways. Ecological studies have shown an association between the overall amount This article is part of a series of papers presented at a symposium entitled ''International Conference on Acute Respiratory Infections'' that was held 7 -of penicillin use in an area and the proportion of penicillin-10 July 1997 in Canberra, Australia. This symposium was organized by the resistant pneumococci [7, 8] dren receiving amoxicillin prophylaxis for recurrent otitis me-
01-19-99 13:29:38 cida UC: CID dia showed that the proportion of children carrying resistant responded to the survey, ú90% agreed with the statements that overuse of antimicrobials contributes to the spread of resispneumococci increased from zero to 25% during prophylaxis and returned to baseline within 3 -5 months after prophylaxis tance and that selective pressure for resistance should be considered in choosing an antimicrobial. In addition, 89% indicated was discontinued [10] . Temporal trends in antimicrobial use and resistance also support an association between the two. that they would be willing to change their diagnostic and therapeutic practices to decrease the spread of resistance (CDC, Since the 1970s, marked increases have occurred in the proportion of children attending out-of-home child care, the number unpublished data).
In the focus group discussions, when physicians were asked of diagnosed episodes of acute otitis media [11] , the rate of pediatric antimicrobial use [12] , and the proportion of pneumoby what proportion they could decrease antibiotic use in their practice without compromising patient care, answers generally coccal strains that are resistant.
ranged between 10% and 50% [16] . Although expectations of parents or patients were identified in the focus groups as the Promoting Judicious Antimicrobial Use leading contributor to antimicrobial overuse, survey results suggested that improving physicians' diagnostic practices and Responses to the emerging threat of resistance must include (1) improved surveillance, with timely feedback to physicians their understanding of the natural history of URIs also are important factors. concerning local resistance patterns; (2) development of diagnostic tests that improve the ability to identify pneumococci To address these factors, the CDC, in collaboration with members of the AAP and the American Academy of Family and other bacterial pathogens; and (3) development of new antimicrobial agents and vaccines that will be effective in treatPhysicians, has published evidence-based recommendations that will identify these and other situations in which antimicroing or preventing resistant infections. Decreasing or even reversing the spread of resistance, however, requires that selecbial use can safely be avoided [17] . Examples include otitis media with effusion [18], most nonstreptococcal pharyngitis, tive pressure of antimicrobial use be reduced. The importance of judicious antimicrobial use as a response to the spread of nonspecific URI including purulent rhinitis [19] , and most episodes of cough illness that currently may be diagnosed as resistance has recently been endorsed by several expert advisory panels [13 -15] .
bronchitis. These recommendations will be promoted as the basis for locally developed practice guidelines, which have The Centers for Disease Control and Prevention (CDC), in collaboration with partner organizations such as the American been shown to be an effective means of changing clinical practices [20] . Academy of Pediatrics (AAP), the American Academy of Family Physicians, and the American Society for Microbiology, A second key element in the strategy to reduce unnecessary antimicrobial use is to decrease patient demand for therapy has initiated a national campaign in the United States to promote more judicious antimicrobial use in outpatient settings.
and to improve the ability of clinicians to respond to patient expectations without an antimicrobial prescription. To educate To achieve a substantial decline in outpatient antimicrobial use will require understanding influences that promote antimicropatients and parents, the CDC is developing pamphlets, posters, and a video to relay the message that antibiotics are not needed bial overuse, identifying clinical situations where use could be substantially curtailed without compromising patient care, and to treat many respiratory infections and that unnecessary antimicrobial therapy can harm patients by increasing their risk convincing medical care providers to change their practices. In part, the ability to change providers' practices will depend of resistant infection. (CDC patient education materials are available free; call (404) 639-4702.) The emphasis of this meson decreasing the consumer demand for antimicrobials.
The initial focus for the campaign is to reduce antimicrobial sage is different from previous ''rational antibiotic use'' campaigns, which focused on taking prescribed medications coruse for several common pediatric respiratory infections. In 1992, an estimated 110 million prescriptions for oral antimicrobial rectly or curtailing overall use for the good of society.
Recommendations that pediatricians educate parents about antidrugs were written by office-based physicians in the United States. The highest rate of antimicrobial use was among children microbial therapy and respiratory infections also are being incorporated into the AAP guidelines for well-child-care visits -õ15 years old (928 prescriptions per 1,000 children), and the leading indications for antimicrobial use were otitis media (ala setting where a clinician may have more time and where parents may be more receptive to the message. most 24 million prescriptions) and nonspecific upper respiratory tract infection (URI) (almost 18 million prescriptions). Overall, Educating the public will be complemented by programs to actively promote judicious antimicrobial use among clinicians. five respiratory diagnoses-otitis media, nonspecific URI, bronchitis, pharyngitis, and sinusitis -accounted for Ç84 million Face-to-face communication between physicians and their peers or drug educators has been effective in changing antiprescriptions, or 76% of all outpatient antimicrobial use [12] .
To identify the factors that result in antimicrobial overuse, microbial-prescribing practices [21, 22] . The formation of state-based coalitions that include the health department, state we conducted surveys of physicians, parents, and pharmacists and held focus group discussions with physicians and parents. medical society, and professional medical-care-provider organizations is being promoted to implement this intervention. 
